查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922713

日本兽药市场规模、份额、趋势及预测（依产品类型、动物种类、给药途径、通路及地区划分，2026-2034年）

Japan Veterinary Medicine Market Size, Share, Trends and Forecast by Product, Animal Type, Route of Administration, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本动物医药市场在2025年达到23亿美元。 IMARC集团预测，到2034年，该市场规模将达到37亿美元，2026年至2034年的复合年增长率为5.22%。推动日本动物医药市场成长的主要因素包括宠物饲养数量的增加、动物健康意识的提高、对伴侣动物照护需求的增长、兽医院数量的增加、政府对牲畜疾病预防的支持以及药物製剂技术的进步。

日本动物医药市场趋势：

伴侣动物数量和支出增加

在日本，宠物拟人化趋势正在稳步推进，越来越多的人将宠物视为家庭成员，并接纳它们进入家中。根据业界报告显示，截至2023年，约有21%的日本受访者拥有宠物，其中犬猫占宠物总数的28.1%。这表明宠物在日本家庭中占据重要地位，并在推动日本动物医药市场成长方面发挥重要作用。犬猫的高比例也支撑了对特定物种药物和兽医服务的持续需求。在都市区，单身家庭的增加和人口老化是推动宠物需求的关键因素。在人口密集的城市，社会孤立现象特别普遍，而宠物能够提供情感支持和陪伴。这种人口结构的变化导致每隻宠物就诊次数增加，并显着扩大了疫苗接种、寄生虫防治和牙科治疗等预防性护理的需求。为此，製药公司正在扩大其针对犬猫的药品产品线，目前已包括治疗皮肤病、消化系统疾病和心臟疾病的药物。

扩大兽医基础设施和技术

日本的兽医服务正透过临床基础设施的现代化和数位技术的整合而不断发展。兽医诊所越来越多地采用诊断影像设备、电子健康记录和先进的手术器械，提高了动物医疗保健的精确度和覆盖范围，这对日本兽医市场的前景产生了积极影响。这一趋势在大都会圈尤其明显，聚集了多家兽医诊所和专科医院。此外，对包括宠物远距医疗在内的数位远端医疗平台的投资也在不断增长。这使得远距咨询和后续观察护理成为可能，这对老年宠物饲主和居住在难以获得面对面医疗服务的农村地区的宠物主人尤其重要。此外，诊断实验室正在扩展其基因检测、抗菌素抗药性筛检和早期疾病检测等服务，这些服务目前在小型动物诊所中的应用也越来越广泛。基础设施的这些发展为不断扩充的药品种类和更高的处方治疗依从性提供了支持。

重点在于畜禽疾病控制和生物安全

由于日本高度依赖畜产品，且需要预防诸如猪瘟和禽流感等疫情的爆发，该国高度重视畜牧业疾病控制和生物安全。此外，政府政策和资金支持措施持续推动全国疾病监测系统、疫苗接种计画和紧急应变通讯协定的实施。农林水产省积极与当地兽医机构和製药公司合作，以确保兽用生技药品和治疗药物的稳定供应。同时，畜牧业对抗菌药物的合理使用日益关注，促使精准医疗方法得以应用，即根据病原体特异性数据调整用药方案。随着畜牧业向永续性和国际合规标准迈进，製药公司正在开发传统抗生素的替代品，进一步扩大在日本动物医药的份额。

本报告解答的关键问题

  • 日本动物医药市场目前发展状况如何？您认为未来几年它将如何发展？
  • 日本动物用药品市场依产品分類的组成是什么？
  • 日本动物医药市场依动物种类分類的组成是怎样的？
  • 日本动物医药市场依给药途径分類的市场组成为何？
  • 日本动物用药品市场按通路的组成是怎样的？
  • 日本兽药市场按地区分類的市场区隔如何？
  • 请介绍一下日本兽药价值链的各个环节。
  • 日本动物医药市场的主要驱动因素和挑战是什么？
  • 日本动物用药品市场的结构是怎么样的？主要参与者有哪些？
  • 日本兽药市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本兽药市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本兽药市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本兽药市场－依产品细分

  • 製药
  • 疫苗
  • 药用饲料添加剂

第七章：日本兽药市场－依动物种类划分

  • 用于生产
  • 伴侣动物

第八章：日本兽药市场－依给药途径细分

  • 口服
  • 肠外
  • 外用

第九章：日本兽药市场－依销售管道细分

  • 兽医医院和诊所
  • 即时检测/院内检测
  • 其他的

第十章：日本兽药市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本兽药市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十二章主要企业概况

第十三章：日本兽药市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章附录

简介目录
Product Code: SR112026A32981

The Japan veterinary medicine market size reached USD 2.30 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 3.70 Billion by 2034 , exhibiting a growth rate (CAGR) of 5.22% during 2026-2034 . The rising pet ownership, growing awareness of animal health, increasing demand for companion animal care, expansion of veterinary clinics, government support for livestock disease control, and advancements in pharmaceutical formulations are some of the key factors driving the veterinary medicine market in Japan.

JAPAN VETERINARY MEDICINE MARKET TRENDS:

Growth in Companion Animal Ownership and Expenditure

Japan is witnessing a steady shift toward pet humanization, with households increasingly adopting companion animals and treating them as family members. According to industry reports, approximately 21% of respondents in Japan reported owning pets, with cats and dogs making up 28.1% of the total pet population in 2023. This highlights the strong presence of companion animals in Japanese households and their significant role in propelling the Japan veterinary medicine market growth. The high proportion of cats and dogs underscores a sustained demand for species-specific pharmaceutical products and veterinary services. In urban regions, the rise of single-person households and the growing elderly population are key factors driving the demand for companion animals. Pets offer emotional support and companionship, especially in densely populated cities where social isolation is more prevalent. This demographic trend is contributing to higher veterinary visits per animal and a notable rise in preventative treatments such as vaccinations, parasite control, and dental care. Pharmaceutical companies are responding by expanding their portfolio of canine and feline medications, which now include therapies for dermatological issues, gastrointestinal conditions, and cardiac care.

Expansion of Veterinary Clinical Infrastructure and Technology

The veterinary services landscape in Japan is evolving through the modernization of clinical infrastructure and the integration of digital technologies. Veterinary clinics are increasingly adopting diagnostic imaging tools, electronic medical records, and advanced surgical equipment to enhance the accuracy and scope of animal healthcare, which is positively impacting Japan veterinary medicine market outlook. This trend is particularly visible in larger urban centers where multi-veterinarian practices and specialty hospitals are becoming more common. In addition to this, increasing investment in digital health platforms, including telemedicine for pets, is also gaining traction. This enables remote consultations and post-treatment monitoring, which is particularly important for aging pet owners or rural communities with limited access to in-person veterinary services. Additionally, diagnostic laboratories are expanding their offerings to include genetic testing, antimicrobial resistance screening, and early disease detection panels, which are now being used more regularly in small animal practices. This infrastructural development supports a broader pharmaceutical product range and higher compliance with prescribed treatments.

Focus on Livestock Disease Management and Biosecurity

Japan places strong regulatory emphasis on livestock disease control and biosecurity, driven by its high dependence on domestic animal products and a need to prevent outbreaks such as swine fever and avian influenza. Moreover, government policies and funding initiatives continue to support the nationwide implementation of disease surveillance systems, vaccination programs, and emergency response protocols. The Ministry of Agriculture, Forestry, and Fisheries (MAFF) actively collaborates with regional veterinary services and pharmaceutical companies to ensure a consistent supply of veterinary biologicals and therapeutics. Additionally, there is growing attention to antimicrobial stewardship in livestock. This is driving the adoption of precision medicine approaches, where drug administration is tailored to pathogen-specific data. As the sector moves toward sustainability and international compliance standards, veterinary pharmaceutical companies are developing alternatives to conventional antibiotics, which is further augmenting Japan veterinary medicine market share.

JAPAN VETERINARY MEDICINE MARKET SEGMENTATION:

Product Insights:

  • Drugs Anti-infective Anti-inflammatory Parasiticide
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Vaccines Inactivated Vaccines Attenuated Vaccines Recombinant Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives Amino Acids Antibiotics
  • Amino Acids
  • Antibiotics
  • Drugs Anti-infective Anti-inflammatory Parasiticide
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Vaccines Inactivated Vaccines Attenuated Vaccines Recombinant Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives Amino Acids Antibiotics
  • Amino Acids
  • Antibiotics
  • Amino Acids
  • Antibiotics
  • Amino Acids
  • Antibiotics

Animal Type Insights:

  • Production
  • Companion
  • Production
  • Companion

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical
  • Oral
  • Parenteral
  • Topical

Distribution Channel Insights:

  • Veterinary Hospitals and Clinics
  • Point-of-Care Testing/In-house Testing
  • Others
  • Veterinary Hospitals and Clinics
  • Point-of-Care Testing/In-house Testing
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan veterinary medicine market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan veterinary medicine market on the basis of product?
  • What is the breakup of the Japan veterinary medicine market on the basis of animal type?
  • What is the breakup of the Japan veterinary medicine market on the basis of route of administration?
  • What is the breakup of the Japan veterinary medicine market on the basis of distribution channel?
  • What is the breakup of the Japan veterinary medicine market on the basis of region?
  • What are the various stages in the value chain of the Japan veterinary medicine market?
  • What are the key driving factors and challenges in the Japan veterinary medicine market?
  • What is the structure of the Japan veterinary medicine market and who are the key players?
  • What is the degree of competition in the Japan veterinary medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Veterinary Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Veterinary Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Veterinary Medicine Market - Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Anti-infective
      • 6.1.3.2 Anti-inflammatory
      • 6.1.3.3 Parasiticide
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Vaccines
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Inactivated Vaccines
      • 6.2.3.2 Attenuated Vaccines
      • 6.2.3.3 Recombinant Vaccines
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 Medicated Feed Additives
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Amino Acids
      • 6.3.3.2 Antibiotics
    • 6.3.4 Market Forecast (2026-2034)

7 Japan Veterinary Medicine Market - Breakup by Animal Type

  • 7.1 Production
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Companion
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)

8 Japan Veterinary Medicine Market - Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Parenteral
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Topical
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)

9 Japan Veterinary Medicine Market - Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Point-of-Care Testing/In-house Testing
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2020-2025)
    • 9.3.2 Market Forecast (2026-2034)

10 Japan Veterinary Medicine Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product
    • 10.1.4 Market Breakup by Animal Type
    • 10.1.5 Market Breakup by Route of Administration
    • 10.1.6 Market Breakup by Distribution Channel
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product
    • 10.2.4 Market Breakup by Animal Type
    • 10.2.5 Market Breakup by Route of Administration
    • 10.2.6 Market Breakup by Distribution Channel
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product
    • 10.3.4 Market Breakup by Animal Type
    • 10.3.5 Market Breakup by Route of Administration
    • 10.3.6 Market Breakup by Distribution Channel
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product
    • 10.4.4 Market Breakup by Animal Type
    • 10.4.5 Market Breakup by Route of Administration
    • 10.4.6 Market Breakup by Distribution Channel
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product
    • 10.5.4 Market Breakup by Animal Type
    • 10.5.5 Market Breakup by Route of Administration
    • 10.5.6 Market Breakup by Distribution Channel
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product
    • 10.6.4 Market Breakup by Animal Type
    • 10.6.5 Market Breakup by Route of Administration
    • 10.6.6 Market Breakup by Distribution Channel
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product
    • 10.7.4 Market Breakup by Animal Type
    • 10.7.5 Market Breakup by Route of Administration
    • 10.7.6 Market Breakup by Distribution Channel
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product
    • 10.8.4 Market Breakup by Animal Type
    • 10.8.5 Market Breakup by Route of Administration
    • 10.8.6 Market Breakup by Distribution Channel
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Veterinary Medicine Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Products Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Products Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Products Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Products Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Products Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Veterinary Medicine Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix